Research & Development



  “看東西還要挑揀時日不成?”   雲瑯蹲下來,重新把包裹包好,站起身道︰“已經備好了,張公可以帶走了。”超碰久久人人摸人人搞,新超碰97在线观人人澡   如果有人能從遙遠的美洲再把辣椒,西紅柿,土豆弄回來,雲瑯就覺得自己的生活已經大圓滿了。哥哥去官网   “說實話,這個世界比我以前待得那個世界好多了,人也善良一些。   長平探手掩住劉徹的衣襟道︰“你小的時候根骨就弱,冰山陰寒,莫要為了貪涼就招來病患。”哥哥日   劉穎愣了一下,一雙縴長白皙的手放在案幾上,輕聲道︰“唐突了。”聲音低沉,竟然有些黯然之意。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo